Prophylactic drug therapy

Looks at a pilot project in Ontario that provided postexposure prophylaxis for HIV. Discusses issues surrounding this practice and makes recommendations for family physicians.

Discusses the results from the Women's Health Initiative Study (WHI) on hormone replacement therapy. Urges for less emphasis on pills for healthy people as prevention tools and more emphasis on healthy living strategies.

Discusses the public health approach to disease prevention, which aims to protect populations of people who are well, using broad, low-risk, and inexpensive measures.

Examines how the precautionary principle focuses on the fundamental changes in public policy that will ultimately be necessary to achieve true cancer prevention.

Reports on a study that calls on the federal government to tighten regulations on drugs being tested and prescribed to prevent disease.

Examines the results of the Women's Health Initiative (WHI) study regarding hormone replacement therapy.

Discusses the different roles of public health and medicine. Argues that the boundaries between the two are blurring with the popularity of chemoprevention.

Discusses chemoprevention experiments, which test potent drugs to prevent disease, and the risks, particularly for Canadian women, of these experiments.